Supplements & Special Projects
Current Issue
In medicine, we tend to think about end-of-life issues as ethical or legal concerns. What would the patient want? What would be in his or her best interest? If he or she cannot decide, who is empowered to make these decisions? We believe that if such issues are addressed and the appropriate legal papers are signed, then the clinical care will correspond to these decisions. But in actual practice this is usually not the case. If there is an available intervention, it will be applied.
Perhaps the best evidence for this comes from a randomized controlled study of palliative care in 100 patien
American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting
Philadelphia, PA; October 17-21, 2009_______________________
Sustained Response in Early Rheumatoid Arthritis with Abatacept
Philadelphia, PA—Two-year data from the AGREE (Abatacept Study to Gauge Remission and Joint Damage Progression in Methotrexate-Naïve Patients with Early Erosive Rheumatoid Arthritis) trial show that patients treated with abatacept in combination with methotrexate (MTX) achieved sustained low disease activity scores at 24 months. Results of
To the Editor,
Given the perplexity of choice, I would like to know if non–high-density lipoprotein (HDL) or APO-B have a role in risk assessment of hyperlipidemia in older adults.
Dr. Frank M. Shanley, FACC
Denville, NJ.
Drs. Arnold and Rich respond:Thank you for your interest in our article.1 Low apolipoprotein A-1 and high apolipoprotein B levels have been shown to be more effective than low-density lipoprotein (LDL) cholesterol levels in predicting myocardial infarction (MI) in some but not all studies involving older adults.2,3 In the Apolipoprotein
I was recently asked to consult on a 93-year-old man, Mr. M, who had fallen and broken his left femur and right humerus. He had underlying dementia and several chronic medical conditions. The patient’s initial liver function tests (LFTs) demonstrated a slightly increased total bilirubin of 2.1 mg/dL, but the rest were all within normal limits: aspartate aminotransferase (AST), 41 IU/L; alkaline phosphatase (ALP), 42 IU/L; and gamma glutamyl transpeptidase (GGT), 14 IU/L. He had a large hematoma in his thigh and upper arm, and a broken left 10th rib. Mr. M was treated acutely for his fracture
Introduction
The Substance Abuse & Mental Health Services Administration (SAMHSA) reported that substance abuse among adults age 60 years and older is a rapidly growing health problem. The report also stated that in 2000, 17% of Americans age 65 and older had problems with prescription drug and alcohol abuse.1 Most elderly people with alcohol abuse problems have a history of early-life alcohol abuse. However, a significant proportion start drinking later in life in response to traumatic life events such as the death of a loved one, loneliness, pain, insomnia, and retirement. This
Introduction
Deficiency of vitamin A is rare in the United States, yet many people take supplemental vitamins that contain vitamin A to prophylactically manage what potentially may ail them. Vitamin A has received much attention, both in the scientific and lay press, that is established in fact, assumption, misinformation, as well as hype. Recent findings on the nutritional and metabolic differences between young and old persons have raised the concern of vitamin A toxicity. Therefore, healthcare professionals should be cognizant of the physiology of retinol, and the benefits and
According to the Alzheimer’s Association, approximately 5.1 million people, or one out of eight people over the age of 65, currently have Alzheimer’s disease (AD). By the year 2030, the number of Americans with this progressive neurologic disorder will reach nearly 7.7 million, and by 2050, between 11 and 16 million.1 The risk of AD is significantly elevated in the African-American and Hispanic populations. Prevalence rates of all types of dementia, including AD, are higher in these groups as compared with non-Hispanic white individuals.2 African-American and Hispanic-American persons have
This article is the second in a continuing series on trauma care and the older adult. The first article of the series, “Trauma in the Elderly: Causes and Prevention,” was published in the January 2010 issue. This series will discuss the growing problem of trauma in the elderly, including its causes and possible ways to prevent it, care in the acute stages, and manifestations and treatment strategies when trauma involves the torso, spine, brain, and hip. Authors include skilled experts in the trauma field representing various specialties at the R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center and the University of Maryland School of Medicine.
Introduction
Case Presentation
A 62-year-old white male presented to a same-day clinic with a complaint of painless, nonpruritic maculopapular lesions on his back, chest, and shoulders. The lesions first appeared 2 weeks prior, and the patient had treated them unsuccessfully with bacitracin ointment. His past medical history was significant for Crohn’s disease, hyperlipidemia, a cerebrovascular accident (CVA), and recurrent methicillin-resistant Staphylococcus aureus (MRSA) furunculosis. Overall, his medical problems were well controlled, and he was compliant with his care. His medications included simvastatin and aspirin, which he had been taking for years. He denied insect exposure and use of new detergents, soaps, lotions, or other skin irritants. Of note, the patient was a wrestling coach and himself a competitive wrestler.
Most biologic capabilities decline with age, although the extent of the decrements are usually modest and vary by function. Cross-sectional studies show that strength declines by approximately 30% from the third through eighth decades and that sensory changes, while difficult to measure, are comparable.1 The effects of disease are superimposed on age-related decreases often resulting in significant functional impairment. Many neuromuscular diseases are uncommon in older persons. This two-part article will focus on the conditions that occur with regularity in older persons or have a striking effect on their lives. Part I discusses cervical spondylotic radiculomyelopathy, lumbar spondylosis, amyotrophic lateral sclerosis (ALS), Guillain-Barré syndrome (GBS), and acquired demyelinating polyneuropathies. Part II, which will be published in the next issue of the Journal, will focus on myasthenia gravis, inclusion body myositis, polymyositis, and polymyalgia rheumatica.
Clinical Geriatrics Blogs
Coming in Future Issues of Clinical Geriatrics
CME Resource Center
THE BURDEN OF PARKINSON’S DISEASE AND THE NEED FOR EARLY DIAGNOSIS AND EARLY TREATMENT
CME Resource Center is currently being updated. Check back soon.










